Fennell, Dean A <br/><br/>
Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  Sep 2012 
 - 1466-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1097/JTO.0b013e318260dfb9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Boronic Acids--therapeutic use<br/>Bortezomib<br/>Disease Progression<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Male<br/>Mesothelioma--drug therapy<br/>Middle Aged<br/>Neoplasm Staging<br/>Pleural Neoplasms--drug therapy<br/>Prognosis<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Pyrazines--therapeutic use<br/>Survival Rate